logo

For the Inventor, By the Inventor

Zeist, Netherlands

Hans B Trijzelaar

This inventor holds 4 USPTO granted patents. Top assignee: Acf Chemiefarma N.v.. Active years: 1984.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hans B Trijzelaar. Retrieved from https://idiyas.com/inventor/hans-b-trijzelaar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 4

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 4

Forward Citations = 38(Granted Patents)


Company Filing History:

goldMedal4 out of 16 
 
Acf Chemiefarma N.v.
 patents

Years Active: 1984

Loading Chart...
4 patents (USPTO):Explore Patents
1. 4472403 - Quinoline derivatives and pharmaceutical compositions and methods for (1984-09-18),
2. 4443453 - Quinoline derivatives, pharmaceutical compositions containing such (1984-04-17),
3. 4442107 - Quinoline derivatives, pharmaceutical compositions containing such (1984-04-10),
4. 4442106 - Quinoline derivatives, pharmaceutical compositions containing such (1984-04-10),

Title: Inventor Hans B. Trijzelaar: Innovating Cardiovascular Solutions

Introduction

Hans B. Trijzelaar is an accomplished inventor based in Zeist, Netherlands. He has made notable contributions to the field of pharmaceuticals with a focus on novel quinoline derivatives. With a total of 4 patents to his name, his work is significant in developing compounds with therapeutic applications, particularly concerning cardiovascular activities.

Latest Patents

Hans B. Trijzelaar's latest inventions include innovative quinoline derivatives and pharmaceutical compositions targeted at cardiovascular health. These inventions involve novel derivatives of quinicine and cinchonicine that demonstrate cardiovascular efficacy. Specifically, the patents focus on the structural formulae of these compounds, which may exist as optically active enantiomers and their therapeutically acceptable salts. Methods for preparing these compounds and their pharmaceutical compositions are also encapsulated within his patents.

Career Highlights

Trijzelaar has dedicated his career to advancing pharmaceutical innovations. As a pivotal member of ACF Chemiefarma N.V., he plays a crucial role in the development of products geared towards improving health outcomes. His patents reinforce his commitment to researching and producing effective pharmaceutical solutions.

Collaborations

In his professional journey, Hans B. Trijzelaar has collaborated with notable colleagues, including Ronus De Bode and Hendricus B. Welle. These partnerships have propelled his research efforts, fostering an environment of innovation and shared expertise within the pharmaceutical sector.

Conclusion

Hans B. Trijzelaar exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through patented inventions not only highlight his expertise but also pave the way for future advancements in cardiovascular therapeutics. Through his work with ACF Chemiefarma N.V. and collaboration with esteemed colleagues, he continues to impact the world of medicine significantly.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…